News, Events & Resources
There’s a lot happening at Melinta. We are the company of the moment and enterprise of the future. Join us in realizing our vision — this is our story, and it’s going to be legendary.
Melinta Therapeutics Announces Two Key Milestones Expanding Reimbursement and Access for KIMYRSA™ (oritavancin)
KIMYRSA™ Receives Product-Specific J-Code and Transitional Pass-Through Status from CMS
Melinta Therapeutics, LLC (“Melinta”), a commercial-stage company focused on the development and commercialization of novel...
Melinta Therapeutics Announces Appointment of Christine Ann Miller as President and Chief Executive Officer
Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage company focused on the development...